Piptaz 2 g/0.25 g (Medicianz) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: piperacillin + tazobactam, piperacillin
Brand name
(ARTG)
: PIPTAZ MEDICIANZ 2 g/0.25 g piperacillin (as sodium) 2 g / tazobactam (as sodium) 0.25 g powder for injection vialWhat this medicine is used for
(ARTG)
Piperacillin/tazobactam is indicated in the treatment of serious bacterial infections caused by susceptible strains of ß-lactamase producing organisms in the conditions listed below:,1. Lower respiratory tract infections,2. Urinary tract infections (complicated and uncomplicated),3. Intra-abdominal infections,4. Skin and skin structure infections,5. Bacterial septicaemia,6. Gynaecological infections,Children under the age of 12 years,In hospitalised children aged 2 to 12 years, piperacillin/tazobactam is indicated for the treatment of serious intra-abdominal infections. It has not been evaluated in this indication for paediatric patients below the age of 2 years.,While piperacillin/tazobactam is indicated only for the conditions listed above, it may be used as a single agent in the treatment of mixed infections caused by piperacillin susceptible and ß-lactamase producing, piperacillin-resistant organisms. Appropriate culture and susceptibility tests should be performed before treatment in order to identify organisms causing infection to determine their susceptibilities to piperacillin/tazobactam. Therapy with piperacillin/tazobactam, however, may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the ß-lactamase producing organisms listed above; however, once these results become available, appropriate therapy should be continued.,In serious infections, presumptive therapy with piperacillin/tazobactam may be initiated before susceptibility test results are available.,Note: For associated bacteraemia due to extended-beta-lactamase (ESBL) producing organisms, see Section 5.1 Pharmacodynamic properties.,Combination therapy with piperacillin/tazobactam and aminoglycosides may be used in the treatment of serious infections caused by Pseudomonas aeruginosa. Both drugs should be used in full therapeutic doses. As soon as results of culture and susceptibility tests become available, antimicrobial therapy should be adjusted.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Intravenous
- a white to off white powder
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Light
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 10 vials pack
- 1 vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient piperacillin + tazobactam
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems